| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Financial Officer | Chief Financial Officer
3 companies
Dhingra Ankur is a Chief Financial Officer at Summit Therapeutics Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 8 buys and 0 sells.
Estimated insider holdings value: $10.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2025 | ILMN Illumina, Inc. | SVP, Chief Financial Officer | Buy | 6,100 | $81.21 | $495,381.00 | +32.4% | +16.2% | - | |
| Mar 26, 2024 | SMMT Summit Therapeutics Inc. | Chief Financial Officer | Buy | 100,000 | $3.75 | $375,000.00 | +39.2% | +113.9% | +431.8% | |
| Dec 13, 2023 | SMMT Summit Therapeutics Inc. | Chief Financial Officer | Buy | 20,400 | $2.17 | $44,254.00 | +4.3% | +84.2% | +663.7% | |
| Mar 7, 2023 | SMMT Summit Therapeutics Inc. | Chief Financial Officer | Buy | 196,362 | $1.05 | $206,180.10 | +514.1% | +34.8% | +250.7% | |
| Aug 16, 2022 | SMMT Summit Therapeutics Inc. | Chief Financial Officer | Buy | 36,215 | $0.97 | $35,128.55 | +90.5% | +4.0% | +76.2% | |
| Nov 24, 2021 | CDNA Caredx, Inc. | Chief Financial Officer | Buy | 5,000 | $42.34 | $211,693.50 | New | -17.0% | -70.9% |